trending Market Intelligence /marketintelligence/en/news-insights/trending/b_CPir8CH9LR2aPv-6argA2 content esgSubNav
In This List

Catalyst Biosciences prices common stock offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Catalyst Biosciences prices common stock offering

Catalyst Biosciences Inc. priced an underwritten public offering of 1,105,263 common shares at $9.50 apiece for expected gross proceeds of about $10.5 million.

The offering is expected to close Dec. 22.

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. are acting as joint book-running managers. LifeSci Capital LLC is acting as a co-manager for the proposed offering.